4-((4-AMINO-3-N-BUTOXYPHENYL)AZO)-N,N-BIS(2-HYDROXYETHYL)ANILINE(126335-39-5)
- Name: 4-((4-AMINO-3-N-BUTOXYPHENYL)AZO)-N,N-BIS(2-HYDROXYETHYL)ANILINE
- Synonyms:4-((4-AMINO-3-N-BUTOXYPHENYL)AZO)-N,N-BIS(2-HYDROXYETHYL)ANILINE
- Molecular Formula:C20H28 N4 O3
- Molecular Weight:372.46
- CAS Registry Number:126335-39-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.126335-39-5 4-((4-AMINO-3-N-BUTOXYPHENYL)AZO)-N,N-BIS(2-HYDROXYETHYL)ANILINE
Assay:99%min Appearance:white crystalline powder Package:25KG drum Storage:Store in dry, dark and ventilated place Transportation:by air, by sea, by express Application:intermediate
Min. Order:0
Supplier:Hangzhou Fandachem Co.,Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-571-28800458
Address:Room 5010, No.9 YanAn Road,Hangzhou,Zhejiang,China
- Contact Suppliers
Other Product
- 67299-00-7/Antibiotic A 35512
- 60-20-8/N-guanyltyramine
- 13311-46-1/N,N,N-Tripropyl-1-propanaminium triiodide
- 616-07-9/DL-ornithine
- 637-03-6/Phenylarsine oxide
- 68458-29-7/Linseed oil, polymer with ethylene glycol, glycerol, maleic anhydride, pentaerythritol, phthalic anhydride and soybean oil
- 5559-94-4/2-hydroxy-N-(pyridin-2-yl)benzamide
- 7179-49-9/Lincomycin hydrochloride monohydrate
- 1596-52-7/4,6-Dinitroquinoline 1-oxide
- 17872-39-8/heptacyclo[6.6.0.0~2,6~.0~3,13~.0~4,11~.0~5,9~.0~10,14~]tetradecane (non-preferred name)
- 96437-82-0/1H-Azepinium, hexahydro-1-(3-(5,6-dihydro-6-oxo-11H-pyrido(2,3-b)(1,4)benzodiazepin-11-yl)-3-oxopropyl)-1-methyl-, iodide
- 114101-13-2/Salbupart
- 9051-48-3/Poly[oxy(methyl-1,2-ethanediyl)],R,R'-1,2- ethanediylbis[ö-hydroxy-
- 160955-43-1/Olean-12-en-28-oicacid, 3-[(2-O-b-D-glucopyranosyl-a-L-arabinopyranosyl)oxy]-16-hydroxy-,6-O-b-D-xylopyranosyl-b-D-glucopyranosyl ester, (3b,16a)-
- 6087-41-8/methyl 3,4,6-tri-O-acetyl-2-deoxyhexopyranoside
- 117823-34-4/1(3H)-Isobenzofuranone,3-(acetyloxy)-4-ethylidene-3a,4,7,7a-tetrahydro-5-[(1S)-1,3,3-trimethylcyclohexyl]-,(3S,3aR,4Z,7aR)-
- 133734-11-9/Propanedioic acid,esters,mono[(4aS,6S,6aS,8R,- 9S,11aS,11bS)-tetradecahydro-6-hydroxy-4,4,- 9,11b-tetramethyl-9,11a-methano-11aH-cyclohepta[ a]naphthalen-8-yl] ester
- 9068-38-6/REVERSE TRANSCRIPTASE, M-MLV, RNASEH+
- 126335-39-5/4-((4-AMINO-3-N-BUTOXYPHENYL)AZO)-N,N-BIS(2-HYDROXYETHYL)ANILINE
- 37096-30-3/2-Amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide
- 6872-06-6/2-Methylindoline
- 5806-00-8/22DIMETHYL33DINITROAZOXYBENZENE
- 60149-28-2/(3beta)-6-[(diethylamino)methyl]cholest-5-en-3-ol hydrochloride (1:1)
- 18997-68-7/N-[4-(Dimethylamino)butyl]carbamodithioic acid
- 102489-04-3/Actinomycin P 3 (9CI)
- 67906-58-5/1,5-bis[[4-[(9,10-dihydro-9,10-dioxo-1-anthryl)amino]-9,10-dihydro-9,10-dioxo-1-anthryl]amino]anthraquinone
- 84304-21-2/triethylammonium C-2-oxopropyl 4-oxo-3-phenyl-5-[[3-(4-sulphonatobutyl)benzoxazol-2(3H)-ylidene]ethylidene]-2-thioxoimidazolidine-1-acetate
- 68413-48-9/dibutyl [[bis[(2-ethylhexyl)oxy]phosphinothioyl]thio]succinate
- 22106-60-1/2-[3-chloro-4-(1H-pyrrol-1-yl)phenyl]propanoic acid
- 1597-82-6/PARAMETHASONE ACETATE (200 MG)